Treating Concurrent Substance Use Among Adults
Advisor
Date
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Research Area
Jurisdiction
Other Titles
See at
Abstract
Despite the increased prevalence of individuals using multiple substances at the same time, limited research exists on evidence-based treatment practices that have demonstrated improved outcomes for individuals who use more than one substance. Therefore, there is a need to identify and assess the effectiveness of treatment practices so that clinicians and organizations have the necessary resources and evidence-based practices to assist this population.
The guide presents three evidence-based practices that engage and improve outcomes for individuals with concurrent substance use and concurrent substance use disorders: • FDA-approved phannacotherapy together with counseling to treat two substance combinations: 1. alcohol and cocaine dependence and 2. cocaine and opioid dependence • Contingency management together with FDA-approved pharmacotherapy and counseling to treat two substance combinations: 1. cocaine and opioid use and dependence and 2. cocaine dependence and alcohol and opioid use • Twelve-step facilitation therapy together with FDA-approved pharmacotherapy and counseling to treat two substance combinations: 1. cocaine and opioid dependence and 2. opioid and other substance dependence.
The guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. These approaches will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders.